Skip to main content

Research News

  • Variants in the gene ARMC5 may be associated with high blood pressure among blacks, according to a National Institutes of Health study led by researchers at the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD). The study team identified 17 variants in the ARMC5 gene that were associated with high blood pressure by analyzing genetic research databases that include those of African descent. The study is published in the July 3, 2019, issue of the Journal of the American Heart Association.

    (adsbygoogle = window.adsbygoogle || []).push({});
  • The recent outbreak of Nipah virus in Kerala, which follows one that occurred in 2018, has brought the focus back on bats which are known to host the virus. Using machine learning - a form of artificial intelligence (AI) – an international group of scientists has identified bat species with the potential to host Nipah virus.

  • In a major collaborative effort, researchers at UNMC and the Lewis Katz School of Medicine at Temple University (LKSOM) have for the first time eliminated replication-competent HIV-1 DNA -- the virus responsible for AIDS -- from the genomes of living animals. The study, reported online July 2 in the journal Nature Communications, marks a critical step toward the development of a possible cure for human HIV infection.

  • New results of a 65-year follow-up study of nearly 7,000 Norwegian patients with Multiple Sclerosis (MS) suggest that patients may have a greater overall risk of developing cancer than the general population, with an especially high risk of cancer in respiratory organs, urinary organs and the central nervous system.

  • Detection of malaria infection could become more accurate soon. A team of researchers from Indian Council of Medical Research’s Jabalpur-based National Institute of Research in Tribal Health (NIRTH) has identified a genetic sequence in the body of malaria parasite that promises to help develop a more sensitive diagnostic test for the disease. 

  • A class of immune cells called innate lymphoid cells (ILCs) mediates the body’s initial defense against tuberculosis (TB), according to a report published online today in Nature. Boosting this response may provide a new approach to developing treatments and vaccines against TB, which causes more deaths worldwide than any other single infectious disease. The research was supported in part by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health.  It was conducted by scientists at Washington University School of Medicine in St. Louis in collaboration with scientists at the Africa Health Research Institute in KwaZulu-Natal, South Africa, and other institutions.

Subscribe to Research News